Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

(2011) Robert T. Cass et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoEfficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models

(2011) Noe Reyes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of 16S rRNA methylase genes in Enterobacteriaceae isolates from a Greek University Hospital

(2011) I. Galani et al.   CLINICAL MICROBIOLOGY AND INFECTION

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Synthesis and Spectrum of the Neoglycoside ACHN-490

(2010) J. B. Aggen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combating evolution with intelligent design: the neoglycoside ACHN-490

(2010) Eliana S Armstrong et al.   CURRENT OPINION IN MICROBIOLOGY

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates

(2010) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

(2010) D. Landman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A simple phenotypic method for the differentiation of metallo- -lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates

(2010) A. Tsakris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Use of Boronic Acid Disk Tests To Detect Extended- Spectrum  -Lactamases in Clinical Isolates of KPC Carbapenemase-Possessing Enterobacteriaceae

(2009) A. Tsakris et al.   JOURNAL OF CLINICAL MICROBIOLOGY